Xi-xi Wu
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Individualized Polygenic Risk Score Identifies NASH in the Eastern Asia Region: A Derivation and Validation Study.
Journal: Clinical and translational gastroenterology
Published: October 29, 2020
Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.
Journal: BMJ open diabetes research & care
Published: January 04, 2020
Paeoniflorin Prevents Intestinal Barrier Disruption and Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in Caco-2 Cell Monolayers.
Journal: Inflammation
Published: September 02, 2019
Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis.
Journal: Journal of thoracic disease
Published: August 30, 2019
Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.
Journal: Journal of gastroenterology and hepatology
Published: August 24, 2019
Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram.
Journal: United European gastroenterology journal
Published: May 16, 2019
Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis.
Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis.
Journal: European journal of gastroenterology & hepatology
Published: April 24, 2018
Ethyl 7-methyl-2-((1-methyl-1H-pyrrol-2-yl)methyl-ene)-3-oxo-5-phenyl-3,5-dihydro-2H-thia-zolo[3,2-a]pyrimidine-6-carboxyl-ate.
Journal: Acta crystallographica. Section E, Structure reports online
Published: September 01, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026